Sort
85,873 grants matching “alzheimers”
iPSC-based Model to Study Frontotemporal Dementia Due to MAPT Mutation
$1,540,579Sally Temple · Regenerative Research Foundation · RF1 · FY2025 · NS
Imaging and Analysis Techniques to Construct a Cell Census Atlas of the Human Brain
$1,540,386Bruce Fischl · Massachusetts General Hospital · U01 · FY2021 · MH
Administration
$1,540,356John Morris · Washington University · U19 · FY2014 · AG
Oregon Alzheimer's Disease Center
$1,540,000Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2015 · AG
Oregon Alzheimer's Disease Center
$1,540,000Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2017 · AG
Oregon Alzheimer's Disease Center
$1,540,000Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2016 · AG
The Mechanisms of Alterations in Sleep with Age
$1,539,725Allan Ian Pack · University Of Pennsylvania · P01 · FY2010 · AG
Risk Factors for Future Cognitive Decline and Alzheimers Disease in Older African Americans
$1,539,195Mark A Gluck · Rutgers The State Univ Of Nj Newark · R01 · FY2023 · AG
Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE)
$1,538,710Kristen Jacklin · University Of Minnesota · R01 · FY2021 · AG
IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA
$1,538,583William E Klunk · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · AG
Neuronal avalanches in the neocortex
$1,538,458Dietmar Plenz · National Institute Of Mental Health · ZIA · FY2013 · MH
HRS Yrs 29-34: Covid Antibody Revision
$1,538,248David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2021 · AG
Brain Health and Ethnic Disparities in ADRD Risk: The Case of Arab Americans
$1,538,004Toni Claudette Antonucci · University Of Michigan At Ann Arbor · R01 · FY2022 · AG
A Novel Approach to Molecular Cell Pathologies of Human Down Syndrome and DS-AD
$1,537,729Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2023 · HD
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$1,537,479John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
$1,537,322Michelle M Mielke · Mayo Clinic Rochester · U54 · FY2019 · AG
Mitochondrial Dysfunction in Neurodegeneration of Aging
$1,537,309Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2013 · AG
FRONTOTEMPORAL DEMENTIA: GENES, IMAGES, AND EMOTIONS
$1,537,305University Of California San Francisco · P01 · FY2004 · AG
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
$1,537,273Kejal Kantarci · Mayo Clinic Rochester · U54 · FY2021 · AG
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
$1,537,273Kejal Kantarci · Mayo Clinic Rochester · U54 · FY2022 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,537,081Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
Extreme Longevity, Cognitive Impairment, Alzheimer's Disease and Related Dementias
$1,537,067Paola Sebastiani · Translational Genomics Research Inst · U19 · FY2025 · AG
Are there ethnic differences in brain amyloid and tau in the seventh decade of life?
$1,537,002Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2017 · AG
Investigations of the protein aggregation inhibitor NU-9 and its derivatives: mode of action and impact on Alzheimerâs disease and related dementias
$1,536,774Pembe Hande Ozdinler · Northwestern University At Chicago · R01 · FY2024 · AG
THE ADMINISTRATION CORE (AC)
$1,536,408Beau M Ances · Washington University · U19 · FY2023 · AG